Felbamate

Epilepsia

Volumn 40, Issue SUPPL. 5, 1999, Pages s57-s62

  Pellock, John M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aplastic anemia; Atropaldehyde; Felbamate; Idiosyncratic reactions; Risk factors

Indexed keywords

ANTICONVULSIVE AGENT; FELBAMATE;

ANTICONVULSANT ACTIVITY; APLASTIC ANEMIA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG METABOLISM; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LIVER FAILURE; LIVER TOXICITY; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 0032825747     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00920.x     Document Type: Review

References (32)

1. Leppik IE, Kramer LD, Bourgeois B, et al. Felbamate after withdrawal of other epileptic drugs [Abstract]. Neurology 1990;40:158.
2. Perhach JL, Weliky I, Newton, JJ, et al. Felbamate. In: Meldrum BM, Porter RJ, eds. New anticonvulsant drugs. London, Paris: I. Libbey, 1986:117-23.
3. Pellock JM, Watemberg N. New antiepileptic drugs in children: present and future. Semin Pediatr Neurol 1997;4:9-18.
4. Pellock JM, Brodie MJ. Felbamate: 1997 update. Epilepsia 1997; 38:1261-4.
5. Brodie MJ, Pellock JM. Taming the brain storms: felbamate updated. Lancet 1995;346:918-9.
6. Bourgeois BFD. Felbamate. Semin Pediatr Neurol 1997;4:3-8.
7. White HS, Harmsworth WL, Sofia RD, et al. Felbamate modulates the strychnine-insensitive glycine receptor. Epilepsy Res 1995;20: 41-8.
8. Ticku MK, Kamatchi GL, Sofia RD. Effect of anticonvulsant felbamate on GABA-receptor system. Epilepsia 1991;32:389-91.
9. A receptors. Ann Neurol 1994;35:229-34.
10. 14C] felbamate in healthy men [Abstract]. Epilepsia 1990;31:642.
11. Sachdeo RC, Narang-Sachdeo SK, Howard JR, et al. Steady-state pharmacokinetics and dose proportionality of felbamate after oral administration of 1200, 2400, and 3600 mg/day of felbamate. Epilepsia 1993;34:80.
12. Ward DL, Shumaker RC. Comparative bioavailability of felbamate in healthy men [Abstract]. Epilepsia 1990;31:642.
13. Sachdeo R, Wagner M, Sachdeo S, et al. Steady-state pharmacokinetics of phenytoin when co-administered with Felbatol™ (felbamate). Epilepsia 1992;33(suppl 3):84.
14. Hooper WD, Franklin ME, Glue P, et al. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of β-oxidation. Epilepsia 1996;37:91-7.
15. Howard JR, Dix RK, Shumaker RC, et al. Effect of felbamate on carbamazepine pharmacokinetics. Epilepsia 1992;33(suppl 3): 84-5.
16. Wagner ML, Graves NM, Marineau K, et al. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate. Epilepsia 1991;32:398-406.
17. Leppik IE, Dreifuss FR, Pledger GW, et al. Felbamate for partial seizure: results of a controlled clinical trial. Neurology 1991;41: 1785-9.
18. Bourgeois B, Leppik IE, Sackellares JC, et al. Felbamate: a doubleblind trial in patients undergoing presurgical evaluation of partial seizures. Neurology 1993;43:693-6.
19. Sachdeo R, Kramer LD, Rosenberg A. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 1992;32:386-92.
20. Felbamate Study Group in Lennox-Gastaut syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
21. Dodson WE. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month, open-label study following a randomized clinical trial. Epilepsia 1993;34(suppl 7):S18-24.
22. Sachdeo RC, Murphy JV, Kamin M. Felbamate in juvenile myoclonic epilepsy. Epilepsia 1992;33(suppl 3):84.
23. Hosain S, Nagarajan L, Carson D, et al. Felbamate for refractory infantile spasms. J Child Neurol 1997;12:466-8.
24. Hurst DL, Rolan TD. The use of felbamate to treat infantile spasms. J Child Neurol 1995;10:134-6.
25. Kaufman DW, Kelly JP, Anderson T, et al. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 1997;38:1265-9.
26. Pellock JM. The place of felbamate in epilepsy therapy: evaluating the risks. Drug Safety 1999 [in press].
27. Pellock JM. Carbamazepine side-effects in children and adults. Epilepsia 1987;28:S64-70.
28. Bryant AE, Dreifuss FR. Valproic acid hepatic failures: US experience since 1986. Neurology 1996;46:465-8.
29. Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991; 41:961-4.
30. Pellock JM, Felbamate: current practice opinions [Abstract]. Neurology 1996;46:A175.
31. Thompson CD, Gulden PH, Macdonald TL. Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration. Chem Res Toxicol 1997;10:457-62.
32. Kapetanovic IM, Torchin CD, Thompson CD, et al. A potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro, Drug Metab Disp 1998;26:1089-1095.